259 related articles for article (PubMed ID: 31376289)
1. EphA2-to-YAP pathway drives gastric cancer growth and therapy resistance.
Huang C; Yuan W; Lai C; Zhong S; Yang C; Wang R; Mao L; Chen Z; Chen Z
Int J Cancer; 2020 Apr; 146(7):1937-1949. PubMed ID: 31376289
[TBL] [Abstract][Full Text] [Related]
2. EPHA2 blockade reverses acquired resistance to afatinib induced by EPHA2-mediated MAPK pathway activation in gastric cancer cells and avatar mice.
Chen Z; Liu Z; Zhang M; Huang W; Li Z; Wang S; Zhang C; Dong B; Gao J; Shen L
Int J Cancer; 2019 Nov; 145(9):2440-2449. PubMed ID: 30957241
[TBL] [Abstract][Full Text] [Related]
3. EphA2-YES1-ANXA2 pathway promotes gastric cancer progression and metastasis.
Mao L; Yuan W; Cai K; Lai C; Huang C; Xu Y; Zhong S; Yang C; Wang R; Zeng P; Huang H; Chen Z; Chen Z
Oncogene; 2021 May; 40(20):3610-3623. PubMed ID: 33941853
[TBL] [Abstract][Full Text] [Related]
4. C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer.
Lee PC; Chen ST; Kuo TC; Lin TC; Lin MC; Huang J; Hung JS; Hsu CL; Juan HF; Lee PH; Huang MC
Oncogene; 2020 Mar; 39(13):2724-2740. PubMed ID: 32005975
[TBL] [Abstract][Full Text] [Related]
5. Nonreceptor tyrosine phosphatase 14 promotes proliferation and migration through regulating phosphorylation of YAP of Hippo signaling pathway in gastric cancer cells.
Han X; Sun T; Hong J; Wei R; Dong Y; Huang D; Chen J; Ren X; Zhou H; Tian W; Jia Y
J Cell Biochem; 2019 Oct; 120(10):17723-17730. PubMed ID: 31168824
[TBL] [Abstract][Full Text] [Related]
6. Leukemia inhibitory factor promotes gastric cancer cell proliferation, migration, and invasion via the LIFR-Hippo-YAP pathway.
Bian SB; Yang Y; Liang WQ; Zhang KC; Chen L; Zhang ZT
Ann N Y Acad Sci; 2021 Jan; 1484(1):74-89. PubMed ID: 32827446
[TBL] [Abstract][Full Text] [Related]
7. EPHA2 Is a Predictive Biomarker of Resistance and a Potential Therapeutic Target for Improving Antiepidermal Growth Factor Receptor Therapy in Colorectal Cancer.
Martini G; Cardone C; Vitiello PP; Belli V; Napolitano S; Troiani T; Ciardiello D; Della Corte CM; Morgillo F; Matrone N; Sforza V; Papaccio G; Desiderio V; Paul MC; Moreno-Viedma V; Normanno N; Rachiglio AM; Tirino V; Maiello E; Latiano TP; Rizzi D; Signoriello G; Sibilia M; Ciardiello F; Martinelli E
Mol Cancer Ther; 2019 Apr; 18(4):845-855. PubMed ID: 30824612
[TBL] [Abstract][Full Text] [Related]
8. LKB1 inhibits the proliferation of gastric cancer cells by suppressing the nuclear translocation of Yap and β-catenin.
Ma LG; Bian SB; Cui JX; Xi HQ; Zhang KC; Qin HZ; Zhu XM; Chen L
Int J Mol Med; 2016 Apr; 37(4):1039-48. PubMed ID: 26936013
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblasts promote gastric tumorigenesis through EphA2 activation in a ligand-independent manner.
Hong HN; Won YJ; Shim JH; Kim HJ; Han SH; Kim BS; Kim HS
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1649-1663. PubMed ID: 29948146
[TBL] [Abstract][Full Text] [Related]
10. YAP transcriptionally regulates COX-2 expression and GCCSysm-4 (G-4), a dual YAP/COX-2 inhibitor, overcomes drug resistance in colorectal cancer.
Li W; Cao Y; Xu J; Wang Y; Li W; Wang Q; Hu Z; Hao Y; Hu L; Sun Y; Xu G; Ao G
J Exp Clin Cancer Res; 2017 Oct; 36(1):144. PubMed ID: 29037225
[TBL] [Abstract][Full Text] [Related]
11. Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells.
Azimi A; Tuominen R; Costa Svedman F; Caramuta S; Pernemalm M; Frostvik Stolt M; Kanter L; Kharaziha P; Lehtiö J; Hertzman Johansson C; Höiom V; Hansson J; Egyhazi Brage S
Cell Death Dis; 2017 Aug; 8(8):e3029. PubMed ID: 29048432
[TBL] [Abstract][Full Text] [Related]
12. Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells.
Chang Y; Fu XR; Cui M; Li WM; Zhang L; Li X; Li L; Sun ZC; Zhang XD; Li ZM; You XY; Nan FF; Wu JJ; Wang XH; Zhang MZ
Cancer Med; 2019 Jul; 8(8):3892-3904. PubMed ID: 31124291
[TBL] [Abstract][Full Text] [Related]
13. ProNGF increases breast tumor aggressiveness through functional association of TrkA with EphA2.
Lévêque R; Corbet C; Aubert L; Guilbert M; Lagadec C; Adriaenssens E; Duval J; Finetti P; Birnbaum D; Magné N; Chopin V; Bertucci F; Le Bourhis X; Toillon RA
Cancer Lett; 2019 May; 449():196-206. PubMed ID: 30771434
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
Chen M; Wang M; Xu S; Guo X; Jiang J
Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
[TBL] [Abstract][Full Text] [Related]
15. Imipramine impedes glioma progression by inhibiting YAP as a Hippo pathway independent manner and synergizes with temozolomide.
Wang Y; Wang X; Wang X; Wu D; Qi J; Zhang Y; Wang K; Zhou D; Meng QM; Nie E; Wang Q; Yu RT; Zhou XP
J Cell Mol Med; 2021 Oct; 25(19):9350-9363. PubMed ID: 34469035
[TBL] [Abstract][Full Text] [Related]
16. Yes-associated protein enhances proliferation and attenuates sensitivity to cisplatin in human gastric cancer cells.
Lu T; Sun L; Zhu X
Biomed Pharmacother; 2018 Sep; 105():1269-1275. PubMed ID: 30021363
[TBL] [Abstract][Full Text] [Related]
17. YAP Tyrosine Phosphorylation and Nuclear Localization in Cholangiocarcinoma Cells Are Regulated by LCK and Independent of LATS Activity.
Sugihara T; Werneburg NW; Hernandez MC; Yang L; Kabashima A; Hirsova P; Yohanathan L; Sosa C; Truty MJ; Vasmatzis G; Gores GJ; Smoot RL
Mol Cancer Res; 2018 Oct; 16(10):1556-1567. PubMed ID: 29903769
[TBL] [Abstract][Full Text] [Related]
18. EPHA2 is a mediator of vemurafenib resistance and a novel therapeutic target in melanoma.
Miao B; Ji Z; Tan L; Taylor M; Zhang J; Choi HG; Frederick DT; Kumar R; Wargo JA; Flaherty KT; Gray NS; Tsao H
Cancer Discov; 2015 Mar; 5(3):274-87. PubMed ID: 25542448
[TBL] [Abstract][Full Text] [Related]
19. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
[TBL] [Abstract][Full Text] [Related]
20. Metformin suppresses proliferation and invasion of drug-resistant breast cancer cells by activation of the Hippo pathway.
Liu J; Li J; Chen H; Wang R; Li P; Miao Y; Liu P
J Cell Mol Med; 2020 May; 24(10):5786-5796. PubMed ID: 32281270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
